Literature DB >> 17548825

Molecular dynamics using atomic-resolution structure reveal structural fluctuations that may lead to polymerization of human Cu-Zn superoxide dismutase.

Richard W Strange1, Chin W Yong, William Smith, S Samar Hasnain.   

Abstract

Mutations of the gene encoding Cu-Zn superoxide dismutase (SOD1) cause 20% of the familial cases of the progressive neurodegenerative disease ALS. A growing body of evidence suggests that in familial ALS (FALS) it is the molecular behavior of the metal-depleted SOD1 dimer that leads to a gain of toxic properties by misfolding, unfolding, and aggregation. Structural studies have so far provided static snapshots on the behavior of the wild-type enzyme and some of the FALS mutants. New approaches are required to map out the structural trajectories of the molecule. Here, using our 1.15-A resolution structure of fully metallated human SOD1 and highly parallelized molecular dynamics code on a high-performance capability computer, we have undertaken molecular dynamics calculations to 4,000 ps to reveal the first stages of misfolding caused by metal deletion. Large spatial and temporal fluctuations of the "electrostatic" and "Zn-binding" loops adjacent to the metal-binding sites are observed in the apo-enzyme relative to the fully metallated dimer. These early misfolding events expose the beta-barrels of the dimer to the external environment, allowing close interactions with adjacent molecules. Protection of the beta-edge of the protein can be partially restored by incorporating a single Zn molecule per dimer. These calculations reveal an essential step in the formation of the experimentally observed self-aggregations of metal-depleted FALS mutant SOD1. This result also has implications for the role of demetallated wild-type SOD1 in sporadic cases of ALS, for which the molecular cause still remains undiscovered.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17548825      PMCID: PMC1885824          DOI: 10.1073/pnas.0703857104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Efficient rebuilding of protein structures.

Authors:  G J Kleywegt; T A Jones
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1996-07-01

2.  Sequence and structural determinants of Cu, Zn superoxide dismutase aggregation.

Authors:  Sagar D Khare; Kyle C Wilcox; Peng Gong; Nikolay V Dokholyan
Journal:  Proteins       Date:  2005-11-15

3.  Backbone dynamics of human Cu,Zn superoxide dismutase and of its monomeric F50E/G51E/E133Q mutant: the influence of dimerization on mobility and function.

Authors:  L Banci; I Bertini; F Cramaro; R Del Conte; A Rosato; M S Viezzoli
Journal:  Biochemistry       Date:  2000-08-08       Impact factor: 3.162

4.  Decreased metallation and activity in subsets of mutant superoxide dismutases associated with familial amyotrophic lateral sclerosis.

Authors:  Lawrence J Hayward; Jorge A Rodriguez; Ji W Kim; Ashutosh Tiwari; Joy J Goto; Diane E Cabelli; Joan Selverstone Valentine; Robert H Brown
Journal:  J Biol Chem       Date:  2002-02-19       Impact factor: 5.157

5.  Dissociation of human copper-zinc superoxide dismutase dimers using chaotrope and reductant. Insights into the molecular basis for dimer stability.

Authors:  Peter A Doucette; Lisa J Whitson; Xiaohang Cao; Virgil Schirf; Borries Demeler; Joan Selverstone Valentine; Jeffrey C Hansen; P John Hart
Journal:  J Biol Chem       Date:  2004-10-12       Impact factor: 5.157

6.  Fully metallated S134N Cu,Zn-superoxide dismutase displays abnormal mobility and intermolecular contacts in solution.

Authors:  Lucia Banci; Ivano Bertini; Nicola D'Amelio; Elena Gaggelli; Elisa Libralesso; Irena Matecko; Paola Turano; Joan Selverstone Valentine
Journal:  J Biol Chem       Date:  2005-08-16       Impact factor: 5.157

7.  The structure of holo and metal-deficient wild-type human Cu, Zn superoxide dismutase and its relevance to familial amyotrophic lateral sclerosis.

Authors:  Richard W Strange; Svetlana Antonyuk; Michael A Hough; Peter A Doucette; Jorge A Rodriguez; P John Hart; Lawrence J Hayward; Joan S Valentine; S Samar Hasnain
Journal:  J Mol Biol       Date:  2003-05-09       Impact factor: 5.469

8.  Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase.

Authors:  H X Deng; A Hentati; J A Tainer; Z Iqbal; A Cayabyab; W Y Hung; E D Getzoff; P Hu; B Herzfeldt; R P Roos
Journal:  Science       Date:  1993-08-20       Impact factor: 47.728

9.  Amyloid-like filaments and water-filled nanotubes formed by SOD1 mutant proteins linked to familial ALS.

Authors:  Jennifer Stine Elam; Alexander B Taylor; Richard Strange; Svetlana Antonyuk; Peter A Doucette; Jorge A Rodriguez; S Samar Hasnain; Lawrence J Hayward; Joan Selverstone Valentine; Todd O Yeates; P John Hart
Journal:  Nat Struct Biol       Date:  2003-06

10.  Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis.

Authors:  D R Rosen; T Siddique; D Patterson; D A Figlewicz; P Sapp; A Hentati; D Donaldson; J Goto; J P O'Regan; H X Deng
Journal:  Nature       Date:  1993-03-04       Impact factor: 49.962

View more
  23 in total

1.  Destabilization of the dimer interface is a common consequence of diverse ALS-associated mutations in metal free SOD1.

Authors:  Helen R Broom; Jessica A O Rumfeldt; Kenrick A Vassall; Elizabeth M Meiering
Journal:  Protein Sci       Date:  2015-10-05       Impact factor: 6.725

2.  A structural modeling approach for the understanding of initiation and elongation of ALS-linked superoxide dismutase fibrils.

Authors:  Mattia Falconi; Federico Iacovelli; Alessandro Desideri
Journal:  J Mol Model       Date:  2013-06-19       Impact factor: 1.810

Review 3.  The structural biochemistry of the superoxide dismutases.

Authors:  J J P Perry; D S Shin; E D Getzoff; J A Tainer
Journal:  Biochim Biophys Acta       Date:  2009-11-13

4.  Aggregation propensities of superoxide dismutase G93 hotspot mutants mirror ALS clinical phenotypes.

Authors:  Ashley J Pratt; David S Shin; Gregory E Merz; Robert P Rambo; W Andrew Lancaster; Kevin N Dyer; Peter P Borbat; Farris L Poole; Michael W W Adams; Jack H Freed; Brian R Crane; John A Tainer; Elizabeth D Getzoff
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-14       Impact factor: 11.205

5.  Molecular mechanisms underlying the impact of mutations in SOD1 on its conformational properties associated with amyotrophic lateral sclerosis as revealed with molecular modelling.

Authors:  Nikolay A Alemasov; Nikita V Ivanisenko; Srinivasan Ramachandran; Vladimir A Ivanisenko
Journal:  BMC Struct Biol       Date:  2018-02-05

6.  Dynamical roles of metal ions and the disulfide bond in Cu, Zn superoxide dismutase folding and aggregation.

Authors:  Feng Ding; Nikolay V Dokholyan
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-03       Impact factor: 11.205

7.  Selective association of misfolded ALS-linked mutant SOD1 with the cytoplasmic face of mitochondria.

Authors:  Christine Vande Velde; Timothy M Miller; Neil R Cashman; Don W Cleveland
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-22       Impact factor: 11.205

8.  Structural changes to monomeric CuZn superoxide dismutase caused by the familial amyotrophic lateral sclerosis-associated mutation A4V.

Authors:  Tom Schmidlin; Brian K Kennedy; Valerie Daggett
Journal:  Biophys J       Date:  2009-09-16       Impact factor: 4.033

9.  Structural characterization of zinc-deficient human superoxide dismutase and implications for ALS.

Authors:  Blaine R Roberts; John A Tainer; Elizabeth D Getzoff; Dean A Malencik; Sonia R Anderson; Valerie C Bomben; Kathrin R Meyers; P Andrew Karplus; Joseph S Beckman
Journal:  J Mol Biol       Date:  2007-08-02       Impact factor: 5.469

10.  Metal deficiency increases aberrant hydrophobicity of mutant superoxide dismutases that cause amyotrophic lateral sclerosis.

Authors:  Ashutosh Tiwari; Amir Liba; Se Hui Sohn; Sai V Seetharaman; Osman Bilsel; C Robert Matthews; P John Hart; Joan Selverstone Valentine; Lawrence J Hayward
Journal:  J Biol Chem       Date:  2009-08-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.